Chronic Lyme borreliosis at the root of multiple sclerosis - Is a cure with antibiotics attainable?

Medical Hypotheses

Volumn 64, Issue 3, 2005, Pages 438-448

  Fritzsche, Markus ^a  

^a 8134 Adliswil Switzerland   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90; HYDROXYCHLOROQUINE; MINOCYCLINE; PENICILLIN G; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL TRANSMISSION; BLOOD BRAIN BARRIER; BORRELIA BURGDORFERI; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; DRUG TRANSPORT; ENDEMIC DISEASE; EUROPE; HERXHEIMER REACTION; HUMAN; IMMUNOMODULATION; INFECTION PREVENTION; IXODES; LYME DISEASE; MULTIPLE SCLEROSIS; NEUROANATOMY; NEUROSYPHILIS; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; SEASONAL VARIATION; TREATMENT OUTCOME; TREPONEMA PALLIDUM; WESTERN HEMISPHERE;

ANIMALS; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI GROUP; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYCHLOROQUINE; IXODES; LYME DISEASE; MINOCYCLINE; MULTIPLE SCLEROSIS; PREVALENCE; RECURRENCE; SEASONS; TINIDAZOLE;

ACARI; BORRELIA; BORRELIA BURGDORFERI; IXODES;

EID: 11144315423     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.09.011     Document Type: Article

References (55)

1. P. Marie Sclerose en plaque et maladies infectueuses Prog. Med. 12 1884 287 289
2. M. Vasold Robert Koch 2002 Sprektrum der Wissenschaft Heidelberg
3. D.K. Adams, W.S. Blacklock, and J.A.W. Cluskiie Spirochaetes in ventricular fluid of monkeys inoculated from cases of disseminated sclerosis J. Pathol. Bacteriol. 28 1925 117 118
4. P.K. Coyle Lyme disease A.K. Asbury G.M. McKhann W.I. McDonald P.J. Goadsby J.C. McArthur Diseases of the nervous system 2002 Cambridge University Press Cambridge 1754 1765
5. G. Steiner Spirochäten im menschlichen Gehirn bei multipler Sklerose Der Nervenarzt 8 1928 457 469
6. G. Steiner Acute plaques in multiple sclerosis, their pathogenic significance and the role of spirochaetes as an etiological factor J. Neuropathol. Exp. Neurol. 11 1952 343 372
7. G. Steiner Morphology of Spirochaeta myelophthora in multiple sclerosis J. Neuropathol. Exp. Neurol. 13 1954 221 229
8. V.P. Mursic, G. Wanner, S. Reinhardt, B. Wilske, U. Busch, and W. Marget Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants Infection 24 1996 218 226
9. G.J. Domingue Sr., and H.B. Woody Bacterial persistence and expression of disease Clin. Microbiol. Rev. 10 1997 320 344
10. S. Bergström, L. Noppa, A. Gylfe, and Y. Ostberg Molecular and cellular biology of Borrelia burgdorferi sensu lato J.S. Gray O. Kahl R.S. Lane G. Stanek Lyme borreliosis: biology, epidemiology and control 2002 CAB International Wallingford 175 200
11. O. Brorson, S.H. Brorson, T.H. Henriksen, P.R. Skogen, and R. Schoyen Association between multiple sclerosis and cystic structures in cerebrospinal fluid Infection 29 2001 315 319
12. H.C. Simons Spirochätenbefunde im Liquor bei multipler Sklerose Schweiz. Med. Wschr. 18 1957 544 545
13. N. Satz Klinik der Lyme-B orreliose 2002 Hans Huber Bern
14. D. Fumarola Multiple sclerosis and Borrelia burgdorferi Lancet 8506 1986 575
15. R. Martin, B. Gran, and Y. Zhao Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease J. Autoimmunol. 16 2001 187 192
16. D. Karussis, H.L. Weiner, and O. Abramsky Multiple sclerosis vs Lyme disease: a case presentation to a discussant and a review of the literature Mult. Scler. 5 1999 395 402
17. S. Baig, T. Olsson, B. Hojeberg, and H. Link Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis Neurology 41 1991 581 587
18. L. Reik Jr., L. Smith, A. Khan, and W. Nelson Demyelinating encephalopathy in Lyme disease Neurology 35 1985 267 269
19. C. Wolfson, and P. Talbot Bacterial infection as a cause of multiple sclerosis Lancet 360 2002 352 353
20. M. Fritzsche Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia Int. J. Health Geogr. 1 2002 5
21. J. Kovar, H. Stybrova, and P. Novak Heat shock protein 90 recognized as an iron-binding protein associated with the plasma membrane of HeLa cells Cell. Physiol. Biochem. 14 2004 41 46
22. C.M. Fraser, S. Casjens, and W.M. Huang Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi Nature 390 1997 580 586
23. J.E. Posey, and F.C. Gherardini Lack of a role for iron in the Lyme disease pathogen Science 288 2000 1651 1653
24. C. Ojaimi, C. Brooks, and S. Casjens Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays Infect. Immunol. 71 2003 1689 1705
25. J. Hu, and C. Seeger Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase Proc. Natl. Acad. Sci. USA 93 1996 1060 1064
26. G. Banumathy, V. Singh, and U. Tatu Host chaperones are recruited in membrane-bound complexes by Plasmodium falciparum J. Biol. Chem. 277 2002 3902 3912
27. M.C. Shanafelt, P. Hindersson, and C. Soderberg T cell and antibody reactivity with the Borrelia burgdorferi 60-kDa heat shock protein in Lyme arthritis J. Immunol. 146 1991 3985 3992
28. M. Zhang, H. Hisaeda, and S. Kano Antibodies specific for heat shock proteins in human and murine malaria Microbes. Infect. 3 2001 363 367
29. C. Cid, J.C. Alvarez-Cermeno, E. Camafeita, M. Salinas, and A. Alcazar Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture: implications for demyelination in multiple sclerosis FASEB J. 18 2004 409 411
30. E. Aberer, C. Brunner, and G. Suchanek Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue Ann. Neurol. 26 1989 732 737
31. D.A. Aquino, D. Peng, C. Lopez, and M. Farooq The constitutive heat shock protein-70 is required for optimal expression of myelin basic protein during differentiation of oligodendrocytes Neurochem. Res. 23 1998 413 420
32. D. Chabas, S.E. Baranzini, and D. Mitchell The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease Science 294 2001 1731 1735
33. J.M. van Noort, and A.C. van Sechel The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis Nature 375 1995 798 801
34. J.J. Bajramovic, A.C. Plomp, and A. Goes Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination J. Immunol. 164 2000 4359 4366
35. A. Compston, and A. Coles Multiple sclerosis Lancet 359 2002 1221 1231
36. W.I. McDonald, M.A. Ron, and G. Giovannoni Multiple sclerosis and its pathophysiology A.K. Asbury G.M. McKhann W.I. McDonald P.J. Goadsby J.C. McArthur Diseases of the nervous system 2002 Cambridge University Press Cambridge 1606 1619
37. D.N. Irani, and D.E. Griffin Host responses in central nervous system infection A.K. Asbury G.M. McKhann W.I. McDonald P.J. Goadsby J.C. McArthur Diseases of the nervous system 2002 Cambridge University Press Cambridge 1651 1659
38. O. Brorson, and S.H. Brorson An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole Int. Microbiol. 7 2004 139 142
39. O. Brorson, and S.H. Brorson An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine Int. Microbiol. 5 2002 25 31
40. C.E. Nord, and L. Kager Tinidazole-microbiology, pharmacology and efficacy in anaerobic infections Infection 11 1983 54 60
41. D.J. Krogstad, and P.H. Schlesinger Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum N. Engl. J. Med. 317 1987 542 549
42. R. Wolf, D. Wolf, and V. Ruocco Antimalarials: unapproved uses or indications Clin. Dermatol. 18 2000 17 35
43. B.E. van den Borne, B.A. Dijkmans, H.H. de Rooij, S. le Cessie, and C.L. Verweij Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells J. Rheumatol. 24 1997 55 60
44. R. Fox, and H. Kang Mechanism of action of hydroxychloroquine as an antirheumatic drug Semin. Arthritis Rheum. 23 1993 82 91
45. V. Brundula, N.B. Rewcastle, L.M. Metz, C.C. Bernard, and V.W. Yong Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis Brain 125 2002 1297 1308
46. B.A. Cunha Minocycline versus doxycycline in the treatment of Lyme neuroborreliosis Clin. Infect. Dis. 30 2000 237 238
47. L. Dotevall, and L. Hagberg Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis Clin. Infect. Dis. 30 2000 410 411
48. A. De Maria, and A. Primavera Possibility of the use of oral long-acting tetracyclines in the treatment of Lyme neuroborreliosis Clin. Infect. Dis. 31 2000 848 849
49. M. Yushchenko, F. Weber, and M. Mader Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count J. Neuroimmunol. 110 2000 244 251
50. G. Perides, L.M. Tanner-Brown, M.A. Eskildsen, and M.S. Klempner Borrelia burgdorferi induces matrix metalloproteinases by neural cultures J. Neurosci. Res. 58 1999 779 790
51. S. Chandler, R. Coates, A. Gearing, J. Lury, G. Wells, and E. Bone Matrix metalloproteinases degrade myelin basic protein Neurosci. Lett. 201 1995 223 226
52. J.C. Garcia-Monco, B. Fernandez-Villar, and J.L. Benach Adherence of the Lyme disease spirochete to glial cells and cells of glial origin J. Infect. Dis. 160 1989 497 506
53. G. Perides, M.E. Charness, and L.M. Tanner Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis J. Infect. Dis. 177 1998 401 408
54. K. Gijbels, S. Masure, H. Carton, and G. Opdenakker Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders J. Neuroimmunol. 41 1992 29 34
55. D. Leppert, J. Ford, and G. Stabler Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis Brain 121 1998 2327 2334